Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -2.92% | -.--% |
2022 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
2020 | Novelion Therapeutics Inc. Announces Management Changes | CI |
Sales 2017 | 138.44 189.31 11.55K | Sales 2018 | 130.43 178.36 10.88K | Capitalization | 15.9M 21.75M 1.33B |
---|---|---|---|---|---|
Net income 2017 | -127M -174M -10.6B | Net income 2018 | -108M -148M -9.01B | EV / Sales 2017 | 18,87,512 x |
Net Debt 2017 | 203M 278M 16.94B | Net Debt 2018 | 303M 415M 25.31B | EV / Sales 2018 | 24,47,567 x |
P/E ratio 2017 |
-0.46
x | P/E ratio 2018 |
-0.15
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 0% |
- Stock Market
- Equities
- NVLNF Stock
- NVLN Stock